Results: 4

Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017

Braz. j. infect. dis; 24 (1), 2020
ABSTRACT Background: This study aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis from 2013 to 2017 in a major teaching hospital in China. Methods: Trends in antifungal drug susceptibility of 217 consecutive non-repetitive cryptococcal isolates collected fr...

Caracterización molecular de los aislamientos de Cryptococcus neoformans de pacientes con HIV, Guayaquil, Ecuador

Biomédica (Bogotá); 37 (3), 2017
Resumen Introducción. La neurocriptococosis es una infección fúngica oportunista que representa un alto costo en vidas humanas y para la economía de los países. Sus agentes causales, las especies del complejo Cryptococcus neoformans/Cryptococcus gattii, tienen una fase sexuada y otra asexuada, cua...

Quercetin and rutin as potential agents antifungal against Cryptococcus spp

Braz. j. biol; 76 (4), 2016
Abstract Amphotericin B is a fungicidal substance that is treatment of choice for most systemic fungal infections affecting as cryptococcosis the immunocompromised patients. However, severe side effects have limited the utility of this drug. The aim of this study was to evaluate the antifungal effect of ...

Criptococose: tratamento prognóstico e prevençäo
Cryptococosis: treatment, prognostic and prevention

Arq. bras. med; 66 (5), 1992
O tratamento da criptococose depende do tecido envolvido, da doença predisponente, do mecanismo de defesa do hospedeiro e dos achados liquóricos e sorológicos. O tratamento de escolha para a meningite criptococócica é a combinaçäo de anfotericina B e 5-flucitosina. O fluconazol, das novas drogas, ...